Endovascular treatment for worsening mild stroke with basilar artery blockage
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a procedure to open a blocked artery in the back of the brain (basilar artery) for people who had a mild stroke that later got worse. If you are eligible, you may receive this treatment up to 24 hours after your symptoms worsen.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You had a mild stroke (low NIHSS score) at first, but then your symptoms got worse (more weakness, trouble speaking, or decreased consciousness).
- Your symptoms started more than 24 hours ago, and the worsening happened within the last 24 hours.
- You have a blockage in the basilar or vertebral artery that is confirmed by a scan.
- You have not had major bleeding, recent surgery, or other serious health issues that would make the procedure unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a minimally invasive procedure to remove a blood clot from the basilar artery in the back of the brain is safe and effective for people with mild to moderate stroke symptoms. It may be an option if you have a confirmed blockage and can be treated within 24 hours of stroke onset.
This trial tests if endovascular therapy (a procedure to remove a clot) can help people who have had a stroke in the back part of the brain (basilar artery) and can be treated within 72 hours, even if they are not eligible for clot-dissolving medicine. The treatment may improve recovery compared to standard care alone.
This trial tests a procedure to remove a clot in a major artery in the back of the brain (basilar artery) in patients who have had a large stroke there within the past 24 hours. It aims to see if opening the blocked artery can improve recovery.
This trial tests whether giving a clot-busting medicine (tenecteplase) can help people with a specific type of stroke caused by a basilar artery blockage, even if treatment starts later than usual. It aims to improve brain recovery and function by reopening the blocked artery.
This trial tests a procedure to remove a blood clot from the main artery at the back of the brain (basilar artery) in people who have a large stroke. The goal is to see if this treatment can improve recovery even when the stroke damage is bigger than usual.
This trial tests if a procedure to remove a blood clot from the main artery in the back of the brain (basilar artery) can help people who have a large stroke. The procedure is done within 24 hours of symptom onset, and researchers want to see if it can reduce disability.
Hear when a new Basilar Artery Occlusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.